Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Public ClinicalTrials.gov record NCT00261950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effects of cinacalcet on markers of bone turnover in patients with kidney disease who are receiving dialysis.
Study identification
- NCT ID
- NCT00261950
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Apr 30, 2011
- Completion
- Apr 30, 2011
- Last update posted
- Jul 20, 2014
2006 – 2011
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85012 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Denver | Colorado | 80220 | — |
| Research Site | New Haven | Connecticut | 06511 | — |
| Research Site | Fort Lauderdale | Florida | 33334 | — |
| Research Site | Evanston | Illinois | 60201 | — |
| Research Site | New Orleans | Louisiana | 70121 | — |
| Research Site | Baltimore | Maryland | 21205 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Teaneck | New Jersey | 07666 | — |
| Research Site | Flushing | New York | 11355 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | The Bronx | New York | 10467 | — |
| Research Site | Allentown | Pennsylvania | 18103 | — |
| Research Site | Houston | Texas | 77076 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00261950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2014 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00261950 live on ClinicalTrials.gov.